BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35489048)

  • 1. Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
    Inacio I; Fonseca L; Amado A; Benido V; Ribeiro I; Dores J; Amaral C; Cardoso MH
    Endocr Regul; 2022 Apr; 56(2):87-94. PubMed ID: 35489048
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at Diagnosis.
    Espinosa de Los Monteros AL; Sosa-Eroza E; Gonzalez B; Mendoza V; Mercado M
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3919-3924. PubMed ID: 30060172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own?
    Vilar L; Naves LA; Martins MRA; Ribeiro-Oliveira A
    Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101878. PubMed ID: 38519400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.
    Butz LB; Sullivan SE; Chandler WF; Barkan AL
    Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study.
    Carosi G; Mangone A; Sala E; Del Sindaco G; Mungari R; Cremaschi A; Ferrante E; Arosio M; Mantovani G
    Eur J Endocrinol; 2021 Jul; 185(2):289-297. PubMed ID: 34081617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission criteria for the follow-up of patients with acromegaly.
    Gullu S; Keles H; Delibasi T; Tonyukuk V; Kamel N; Erdogan G
    Eur J Endocrinol; 2004 Apr; 150(4):465-71. PubMed ID: 15080775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
    Ho KY; Weissberger AJ
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
    Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
    Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.
    Subbarayan SK; Fleseriu M; Gordon MB; Brzana JA; Kennedy L; Faiman C; Hatipoglu BA; Prayson RA; Delashaw JB; Weil RJ; Hamrahian AH
    Endocr Pract; 2012; 18(6):817-25. PubMed ID: 22784832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.
    Niculescu D; Purice M; Coculescu M
    Pituitary; 2013 Jun; 16(2):168-74. PubMed ID: 22562529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
    Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
    Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR.
    Machado EO; Taboada GF; Neto LV; Haute FRV; Corrêa LL; Balarini GA; Shrank Y; Goulart M; Gadelha MR
    Growth Horm IGF Res; 2008 Oct; 18(5):389-393. PubMed ID: 18348909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.